3-Dimensional Pharmaceuticals thrombin inhibitor deal with Wyeth carries maximum value of $112 mil..

Executive Summary

3-DIMENSIONAL PHARMACEUTICALS IPO WITHIN TWELVE MONTHS is planned by the Exton, Penn. company. The drug discovery firm is currently talking to investment bankers about an initial public offering and will be preparing an S-1 registration statement for the Securities & Exchange Commission in the near future, 3DP said. The company reports current cash resources of about $15 mil., sufficient to fund two to three years of operations. 3DP completed a $12.5 mil. round of equity financing in March, led by Rho Management.